These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20021530)

  • 41. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period.
    Goel A; Maski MR; Bajracharya S; Wenger JB; Zhang D; Salahuddin S; Shahul SS; Thadhani R; Seely EW; Karumanchi SA; Rana S
    Circulation; 2015 Nov; 132(18):1726-33. PubMed ID: 26416810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of amlodipine besylate at delivery and during lactation.
    Morgan JL; Kogutt BK; Meek C; Stehel EK; McIntire DD; Sheffield JS; Roberts SW
    Pregnancy Hypertens; 2018 Jan; 11():77-80. PubMed ID: 29523279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.
    Brewster LM; Seedat YK
    BMC Med; 2013 May; 11():141. PubMed ID: 23721258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
    Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH
    Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in drugs against hypertension.
    Neelima ; Bhat BK; Bhaduri AP
    Prog Drug Res; 1985; 29():215-76. PubMed ID: 2868487
    [No Abstract]   [Full Text] [Related]  

  • 48. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update in pharmacologic treatment of hypertension.
    Ferdinand KC
    Cardiol Clin; 2001 May; 19(2):279-94, v. PubMed ID: 11407110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. National recommendations for the pharmacological treatment of hypertension: should they be revised?
    Moser M
    Arch Intern Med; 1999 Jul; 159(13):1403-6. PubMed ID: 10399891
    [No Abstract]   [Full Text] [Related]  

  • 52. [The treatment of arterial hypertension: new trials--new approaches].
    Karpov IuA
    Kardiologiia; 2003; 43(9):87-90. PubMed ID: 14682300
    [No Abstract]   [Full Text] [Related]  

  • 53. Better risk assessment for individual substances.
    Freudenmann RW; Freudenmann N; Zurowski B; Schönfeldt-Lecuona C; Connemann BJ; Gahr M
    Dtsch Arztebl Int; 2015 Feb; 112(7):120. PubMed ID: 25780871
    [No Abstract]   [Full Text] [Related]  

  • 54. Pressor responses to antihypertensive drug types.
    Alderman MH; Cohen HW; Sealey JE; Laragh JH
    Am J Hypertens; 2010 Sep; 23(9):1031-7. PubMed ID: 20725055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular outcomes and antihypertensive drug treatment in older women.
    Staessen JA; Thijs L; Wang J; Li Y
    JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811972
    [No Abstract]   [Full Text] [Related]  

  • 56. Cardiovascular outcomes and antihypertensive drug treatment in older women.
    Bursztyn M
    JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811971
    [No Abstract]   [Full Text] [Related]  

  • 57. Approach to Antihypertensive Therapy.
    Reddy P; Dupree L
    Am J Ther; 2016; 23(2):e451-73. PubMed ID: 25719531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.
    Bradley HA; Wiysonge CS; Volmink JA; Mayosi BM; Opie LH
    J Hypertens; 2006 Nov; 24(11):2131-41. PubMed ID: 17053529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In reply.
    Weber F; Anlauf M
    Dtsch Arztebl Int; 2015 Feb; 112(7):120. PubMed ID: 25780872
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypertension: just the facts.
    Sharp K
    Clin J Oncol Nurs; 2006 Dec; 10(6):727-9. PubMed ID: 17193939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.